REQUEST A DEMO
Total
USD $0.00
Search more companies

Boehringer Ingelheim S A (Colombia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Boehringer Ingelheim S A Profile Updated: January 28, 2020
Buy our report for this company USD 29.95 Most recent financial data: 2019 Available in: English & Spanish Download a sample report

Boehringer Ingelheim is a worldwide operating affiliated group of companies with 42,224 employees. The organisation structure has two main business areas: Human Pharmaceuticals and Animal Health.

Headquarters
Cr 11 84A 09 P 5
Bogota D.C.; Bogota D.C; Postal Code: 0806

Contact Details: Purchase the Boehringer Ingelheim S A report to view the information.

Basic Information
Total Employees:
Purchase the Boehringer Ingelheim S A report to view the information.
Registered Capital:
Purchase the Boehringer Ingelheim S A report to view the information.
Ratings:
Purchase the Boehringer Ingelheim S A report to view the information.
Incorporation Date:
May 31, 1972
Key Executives
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Boehringer Ingelheim S A report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
35%
Total operating revenue
26.85%
Operating profit (EBIT)
-60.34%
EBITDA
-29%
Net Profit (Loss) for the Period
-79.67%
Total assets
46.65%
Total equity
N/A
Operating Profit Margin (ROS)
-1.52%
Net Profit Margin
-1.18%
Return on Equity (ROE)
N/A
Debt to Equity Ratio
N/A
Quick Ratio
0.02%
Cash Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?